Financhill
Buy
66

CLS.TO Quote, Financials, Valuation and Earnings

Last price:
$415.77
Seasonality move :
6.64%
Day range:
$413.19 - $424.12
52-week range:
$82.66 - $512.83
Dividend yield:
0%
P/E ratio:
48.52x
P/S ratio:
3.07x
P/B ratio:
16.95x
Volume:
337.9K
Avg. volume:
701.2K
1-year change:
196.36%
Market cap:
$47.8B
Revenue:
$13.2B
EPS (TTM):
$8.57

Earnings Data

Next earnings date for CLS.TO
Jan 28
2026
Most recent earnings per share
$3.18
Beat by $1.10
(Oct 27/2025)
Consensus Estimate
$2.08
(Oct 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CLS.TO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/28/2026 Q4 $4.8B -- -- $2.42 --
10/27/2025 Q3 $4.3B $4.4B $3.18 $2.08 $1.10
07/28/2025 Q2 $3.6B $4B $2.52 $1.68 $0.84
04/24/2025 Q1 $3.5B $3.8B $1.06 $1.55 -$0.49
01/29/2025 Q4 $3.6B $3.6B $1.81 $1.52 $0.29
10/23/2024 Q3 $3.3B $3.4B $1.05 $1.29 -$0.24
07/24/2024 Q2 $3.1B $3.3B $1.14 $1.12 $0.02
04/24/2024 Q1 $3B $3B $1.15 $1.02 $0.13
01/29/2024 Q4 $2.8B $2.9B $1.04 $0.91 $0.13
10/25/2023 Q3 -- $2.7B $0.84 -- --
07/26/2023 Q2 -- $2.6B $0.64 -- --
04/26/2023 Q1 -- $2.5B $0.23 -- --
01/25/2023 Q4 -- $2.8B $0.47 -- --
10/24/2022 Q3 -- $2.5B $0.48 -- --
07/25/2022 Q2 -- $2.2B $0.37 -- --
04/27/2022 Q1 -- $2B $0.22 -- --
01/26/2022 Q4 -- $1.9B $0.32 -- --
10/26/2021 Q3 -- $1.8B $0.35 -- --
07/26/2021 Q2 -- $1.7B $0.25 -- --
04/29/2021 Q1 -- $1.6B $0.10 -- --
01/27/2021 Q4 -- $1.8B $0.20 -- --
10/28/2020 Q3 -- $2.1B $0.31 -- --
07/29/2020 Q2 -- $2.1B $0.14 -- --
04/29/2020 Q1 -- $1.8B -$0.03 -- --
01/29/2020 Q4 -- $2B -$0.07 -- --
10/24/2019 Q3 -- $2B -$0.07 -- --
07/24/2019 Q2 -- $1.9B -$0.06 -- --
04/25/2019 Q1 -- $1.9B $0.88 -- --
01/31/2019 Q4 -- $2.3B $0.58 -- --
10/24/2018 Q3 -- $2.2B $0.08 -- --
07/31/2018 Q2 -- $2.2B $0.15 -- --
04/27/2018 Q1 -- $1.9B $0.13 -- --
01/24/2018 Q4 -- $2B $0.12 -- --
10/26/2017 Q3 -- $1.9B $0.30 -- --
07/25/2017 Q2 -- $2.1B $0.32 -- --
04/20/2017 Q1 -- $2B $0.21 -- --
01/26/2017 Q4 -- $2.2B $0.20 -- --
10/20/2016 Q3 -- $2B $0.48 -- --
07/21/2016 Q2 -- $1.9B $0.32 -- --
04/21/2016 Q1 -- $1.9B $0.25 -- --
01/27/2016 Q4 -- $2B $0.11 -- --

Celestica, Inc. Earnings Questions

  • How Much did Celestica, Inc. Generate in Revenue Last Quarter?

    Celestica, Inc. reported $4.4B worth of top line sales in its most recent quarter.

  • Did Celestica, Inc. Beat Earnings Last Quarter?

    Celestica, Inc. announced earnings per share of $3.18 which represents a beat of analyst forecast a $2.08 per share.

  • Is Celestica, Inc. Profitable?

    Celestica, Inc. reported $511.4M that represents $4.41 per share over the last quarter.

  • What is the Analyst Consensus for Celestica, Inc. EPS Next Year?

    Celestica, Inc.'s earnings are forecast to grow from $4.94 per share to $5.57 per share next year representing an increase of 65.43%.

  • When is Celestica, Inc.'s Earnings Date?

    Celestica, Inc.'s next earnings date is January 28, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

Sell
32
SMX alert for Dec 24

SMX (Security Matters) Plc [SMX] is down 8.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock